Second Thoughts on Safety of Avandia Stir a Dispute

In a highly unusual move, the agency has decided to reopen the case on Avandia and will ask a committee whether it should reconsider the restrictions on the drug.    

Source: NYT Health - June 2, 2013 Category: Consumer Health News Authors: By KATIE THOMAS and SABRINA TAVERNISE Tags: Heart Drugs (Pharmaceuticals) Avandia (Drug) Food and Drug Administration Merck & Company Inc MRK NYSE Diabetes GlaxoSmithKline PLC GSK NYSE Source Type: news